China Journal of Leprosy and Skin Diseases ›› 2024, Vol. 40 ›› Issue (4): 274-277.doi: 10.12144/zgmfskin202404274

• Case Reports • Previous Articles     Next Articles

Nail lichen planus successfully treated by tofacitinib: a case report

YUAN Ruiqing1,2, CHEN Shengli1,2, LIU Hong1,2, SHI Zhongxiang1,2   

  1. 1 Hospital for Skin Diseases, Shandong First Medical University, Jinan 250022, China; 2 Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences, Jinan 250022, China
  • Online:2024-04-15 Published:2024-03-26

PDF (PC)

38

Like

Abstract: There is no standard treatment scheme for lichen planus nail at present, and traditional treatment is limited due to severe pain and other side effects and poor efficacy. Tofacitinib is an oral, small-molecule JAK inhibitor that inhibits all JAKs, especially JAK1 and JAK3. We reported a case with lichen planus successfully treated by tofacitinib.

Key words: tofacitinib, nail lichen planus, JAK inhibitor